Trinity Biotech (TRIB) has released an update.
Trinity Biotech plc is set to hold its Annual General Meeting on September 30, 2024, where shareholders will vote on key resolutions, including the reappointment of Grant Thornton as auditors and Dr. Andrew Omidvar as a director. The Board recommends voting in favor of all resolutions, highlighting their confidence that these actions are in the best interests of the company and its shareholders.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
